FDAnews
www.fdanews.com/articles/159466-quest-to-offer-genetic-test-for-breast-cancer-risk

Quest to Offer Genetic Test for Breast Cancer Risk

October 16, 2013
Quest Diagnostics became the largest U.S. company to start offering gene-based tests for inherited forms of breast cancer since the U.S. Supreme Court ended Myriad Genetics’ monopoly on the tests for specific gene mutations.
Reuters